The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease

N. C. Bodick, W. W. Offen, H. E. Shannon, J. Satterwhite, R. Lucas, R. Van Lier, S. M. Paul

Research output: Contribution to journalArticle

100 Scopus citations

Fingerprint Dive into the research topics of 'The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease'. Together they form a unique fingerprint.

Medicine & Life Sciences